Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26, 1276-1284.
Abbracchio, M.P., and Burnstock, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64, 445-475.
Abbracchio, M.P., Burnstock, G., Boeynaems, J.M., Barnard, E.A., Boyer, J.L., Kennedy, C., Knight, G.E., Fumagalli, M., Gachet, C., Jacobson, K.A., et al. (2006). International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58, 281-341.
Abbracchio, M.P., Burnstock, G., Verkhratsky, A., and Zimmermann, H. (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci 32, 19-29.
Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M.S., Tomasini, L., Ferrandino, A.F., Rosenberg Belmaker, L.A., Szekely, A., Wilson, M., et al. (2012). Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442.
Agarwal, S., Loh, Y.H., McLoughlin, E.M., Huang, J., Park, I.H., Miller, J.D., Huo, H., Okuka, M., Dos Reis, R.M., Loewer, S., et al. (2010). Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296.
Ahlberg, J., Marzella, L., and Glaumann, H. (1982). Uptake and degradation of proteins by isolated rat liver lysosomes.
Suggestion of a microautophagic pathway of proteolysis. Lab Invest 47, 523-532.
Alba, M.M., and Guigo, R. (2004). Comparative analysis of amino acid repeats in rodents and humans. Genome Res 14, 549-554.
Albrecht, M., Golatta, M., Wullner, U., and Lengauer, T. (2004). Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem 271, 3155-3170.
Alexander, A., Cai, S.L., Kim, J., Nanez, A., Sahin, M., MacLean, K.H., Inoki, K., Guan, K.L., Shen, J., Person, M.D., et al.
(2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107, 4153-4158.
Allsopp, T.E., Kiselev, S., Wyatt, S., and Davies, A.M. (1995). Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur J Neurosci 7, 1266-1272.
Allsopp, T.E., Wyatt, S., Paterson, H.F., and Davies, A.M. (1993). The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73, 295-307.
Alonso, E., Martinez-Ruano, L., De Biase, I., Mader, C., Ochoa, A., Yescas, P., Gutierrez, R., White, M., Ruano, L., Fragoso-Benitez, M., et al. (2007). Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Mov Disord 22, 1050-1053.
Alves, S., Regulier, E., Nascimento-Ferreira, I., Hassig, R., Dufour, N., Koeppen, A., Carvalho, A.L., Simoes, S., de Lima, M.C., Brouillet, E., et al. (2008). Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Hum Mol Genet 17, 2071-2083.
Amit, M., Carpenter, M.K., Inokuma, M.S., Chiu, C.P., Harris, C.P., Waknitz, M.A., Itskovitz-Eldor, J., and Thomson, J.A. (2000).
Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227, 271-278.
Amit, M., and Itskovitz-Eldor, J. (2002). Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200, 225-232.
Andrews, P.W., Banting, G., Damjanov, I., Arnaud, D., and Avner, P. (1984). Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3, 347-361.
Ansari, N., Hadi-Alijanvand, H., Sabbaghian, M., Kiaei, M., and Khodagholi, F. (2014). Interaction of 2-APB, dantrolene, and TDMT with IP3R and RyR modulates ER stress-induced programmed cell death I and II in neuron-like PC12 cells: an experimental and computational investigation. J Biomol Struct Dyn 32, 1211-1230.
Antony, P.M., Mantele, S., Mollenkopf, P., Boy, J., Kehlenbach, R.H., Riess, O., and Schmidt, T. (2009). Identification and functional dissection of localization signals within ataxin-3. Neurobiol Dis 36, 280-292.
Anwyl, R. (1999). Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 29, 83-120.
Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.
Arstila, A.U., and Trump, B.F. (1968). Studies on cellular autophagocytosis. The formation of autophagic vacuoles in the liver after glucagon administration. Am J Pathol 53, 687-733.
Arthur, D.B., Akassoglou, K., and Insel, P.A. (2005). P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci U S A 102, 19138-19143.
Artola, A., and Singer, W. (1987). Long-term potentiation and NMDA receptors in rat visual cortex. Nature 330, 649-652.
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge, R. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17, 126-140.
Babaie, Y., Herwig, R., Greber, B., Brink, T.C., Wruck, W., Groth, D., Lehrach, H., Burdon, T., and Adjaye, J. (2007). Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25, 500-510.
Bao, S., Tang, F., Li, X., Hayashi, K., Gillich, A., Lao, K., and Surani, M.A. (2009). Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461, 1292-1295.
Bar-Nur, O., Russ, H.A., Efrat, S., and Benvenisty, N. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9, 17-23.
Bardoni, R., Goldstein, P.A., Lee, C.J., Gu, J.G., and MacDermott, A.B. (1997). ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci 17, 5297-5304.
Barker, J.L., Dufy, B., Owen, D.G., and Segal, M. (1983). Excitable membrane properties of cultured central nervous system neurons and clonal pituitary cells. Cold Spring Harb Symp Quant Biol 48 Pt 1, 259-268.
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyssegur, J., and Mazure, N.M. (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29, 2570-2581.
Ben-Yosef, D., Malcov, M., and Eiges, R. (2008). PGD-derived human embryonic stem cell lines as a powerful tool for the study of human genetic disorders. Mol Cell Endocrinol 282, 153-158.
Berger, Z., Ravikumar, B., Menzies, F.M., Oroz, L.G., Underwood, B.R., Pangalos, M.N., Schmitt, I., Wullner, U., Evert, B.O., O'Kane, C.J., et al. (2006). Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15, 433-442.
Berke, S.J., Chai, Y., Marrs, G.L., Wen, H., and Paulson, H.L. (2005). Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem 280, 32026-32034.
Berke, S.J., and Paulson, H.L. (2003). Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev 13, 253-261.
Berridge, M.J. (1998). Neuronal calcium signaling. Neuron 21, 13-26.
Bettencourt, B.R., Hogan, C.C., and Nimali, M. (2007). Polyglutamine expansion in Drosophila: thermal stress and Hsp70 as selective agents. J Biosci 32, 537-547.
Bettencourt, C., Santos, C., Kay, T., Vasconcelos, J., and Lima, M. (2008). Analysis of segregation patterns in Machado-Joseph disease pedigrees. J Hum Genet 53, 920-923.
Bhattacharyya, A., Thakur, A.K., Chellgren, V.M., Thiagarajan, G., Williams, A.D., Chellgren, B.W., Creamer, T.P., and Wetzel, R. (2006). Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol 355, 524-535.
Bichelmeier, U., Schmidt, T., Hubener, J., Boy, J., Ruttiger, L., Habig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W.J., et al.
(2007). Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci 27, 7418-7428.
Bignami, A., Eng, L.F., Dahl, D., and Uyeda, C.T. (1972). Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 43, 429-435.
Bilen, J., and Bonini, N.M. (2007). Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3, 1950-1964.
Blommaart, E.F., Krause, U., Schellens, J.P., Vreeling-Sindelarova, H., and Meijer, A.J. (1997). The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243, 240-246.
Bockaert, J., Pin, J., and Fagni, L. (1993). Metabotropic glutamate receptors: an original family of G protein-coupled receptors.
Fundam Clin Pharmacol 7, 473-485.
Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B.O., Muller, E.C., Lurz, R., Breuer, P., Schugardt, N., et al. (2006). An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J 25, 1547-1558.
Boiani, M., and Scholer, H.R. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6, 872-884.
Bongaerts, G.P., and Severijnen, R.S. (2007). Stem cells from residual IVF-embryos - Continuation of life justifies isolation. Med Hypotheses 69, 478-480.
Borghese, L., Dolezalova, D., Opitz, T., Haupt, S., Leinhaas, A., Steinfarz, B., Koch, P., Edenhofer, F., Hampl, A., and Brustle, O. (2010). Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells 28, 955-964.
Bottenstein, J.E., and Harvey, A.L. (1985). Cell Culture in the Neurosciences. Plenum Press: New York and London, 3.
Boulting, G.L., Kiskinis, E., Croft, G.F., Amoroso, M.W., Oakley, D.H., Wainger, B.J., Williams, D.J., Kahler, D.J., Yamaki, M., Davidow, L., et al. (2011). A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29, 279-286.
Bourguignon, L.Y., Peyrollier, K., Xia, W., and Gilad, E. (2008). Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283, 17635-17651.
Boy, J., Schmidt, T., Schumann, U., Grasshoff, U., Unser, S., Holzmann, C., Schmitt, I., Karl, T., Laccone, F., Wolburg, H., et al.
(2009). A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats. Neurobiol Dis 37, 284-293.
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956.
Brake, A.J., Wagenbach, M.J., and Julius, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371, 519-523.
Brennand, K., Savas, J.N., Kim, Y., Tran, N., Simone, A., Hashimoto-Torii, K., Beaumont, K.G., Kim, H.J., Topol, A., Ladran, I., et al. (2014). Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry.
Brons, I.G., Smithers, L.E., Trotter, M.W., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, S.M., Howlett, S.K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R.A., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195.
Brusco, A., Gellera, C., Cagnoli, C., Saluto, A., Castucci, A., Michielotto, C., Fetoni, V., Mariotti, C., Migone, N., Di Donato, S., et al. (2004). Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61, 727-733.
Bryer, A., Krause, A., Bill, P., Davids, V., Bryant, D., Butler, J., Heckmann, J., Ramesar, R., and Greenberg, J. (2003). The hereditary adult-onset ataxias in South Africa. J Neurol Sci 216, 47-54.
Burk, K., Globas, C., Bosch, S., Klockgether, T., Zuhlke, C., Daum, I., and Dichgans, J. (2003). Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250, 207-211.
Burnett, B., Li, F., and Pittman, R.N. (2003). The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12, 3195-3205.
Burnett, B.G., and Pittman, R.N. (2005). The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.
Proc Natl Acad Sci U S A 102, 4330-4335.
Burnstock, G. (1972). Purinergic nerves. Pharmacol Rev 24, 509-581.
Burnstock, G. (1976). Do some nerve cells release more than one transmitter? Neuroscience 1, 239-248.
Burnstock, G. (2004). Cotransmission. Curr Opin Pharmacol 4, 47-52.
Burnstock, G. (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87, 659-797.
Butland, S.L., Devon, R.S., Huang, Y., Mead, C.L., Meynert, A.M., Neal, S.J., Lee, S.S., Wilkinson, A., Yang, G.S., Yuen, M.M., et al. (2007). CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8, 126.
Caccamo, D., Katsetos, C.D., Herman, M.M., Frankfurter, A., Collins, V.P., and Rubinstein, L.J. (1989). Immunohistochemistry of a spontaneous murine ovarian teratoma with neuroepithelial differentiation. Neuron-associated beta-tubulin as a marker for primitive neuroepithelium. Lab Invest 60, 390-398.
Camden, J.M., Schrader, A.M., Camden, R.E., Gonzalez, F.A., Erb, L., Seye, C.I., and Weisman, G.A. (2005). P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem 280, 18696-18702.
Camello, C., Lomax, R., Petersen, O.H., and Tepikin, A.V. (2002). Calcium leak from intracellular stores--the enigma of calcium signalling. Cell Calcium 32, 355-361.
Cancel, G., Abbas, N., Stevanin, G., Durr, A., Chneiweiss, H., Neri, C., Duyckaerts, C., Penet, C., Cann, H.M., Agid, Y., et al.
(1995). Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet 57, 809-816.
Cao, F., Levine, J.J., Li, S.H., and Li, X.J. (2001). Nuclear aggregation of huntingtin is not prevented by deletion of chaperone Hsp104. Biochim Biophys Acta 1537, 158-166.
Carvalho, D.R., La Rocque-Ferreira, A., Rizzo, I.M., Imamura, E.U., and Speck-Martins, C.E. (2008). Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol 38, 296-299.
Cecchi, C., Pensalfini, A., Liguri, G., Baglioni, S., Fiorillo, C., Guadagna, S., Zampagni, M., Formigli, L., Nosi, D., and Stefani, M.
(2008). Differentiation increases the resistance of neuronal cells to amyloid toxicity. Neurochem Res 33, 2516-2531.
Chai, Y., Berke, S.S., Cohen, R.E., and Paulson, H.L. (2004). Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 279, 3605-3611.
Chai, Y., Koppenhafer, S.L., Bonini, N.M., and Paulson, H.L. (1999a). Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci 19, 10338-10347.
Chai, Y., Koppenhafer, S.L., Shoesmith, S.J., Perez, M.K., and Paulson, H.L. (1999b). Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Hum Mol Genet 8, 673-682.
Chai, Y., Shao, J., Miller, V.M., Williams, A., and Paulson, H.L. (2002). Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 99, 9310-9315.
Chai, Y., Wu, L., Griffin, J.D., and Paulson, H.L. (2001). The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 276, 44889-44897.
Chakiath, C.S., and Esposito, D. (2007). Improved recombinational stability of lentiviral expression vectors using reduced-genome Escherichia coli. Biotechniques 43, 466, 468, 470.
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., Vrana, J., Jones, K., Grotewold, L., and Smith, A.
(2007). Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234.
Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M., Sadelain, M., and Studer, L. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275-280.
Chambers, S.M., Qi, Y., Mica, Y., Lee, G., Zhang, X.J., Niu, L., Bilsland, J., Cao, L., Stevens, E., Whiting, P., et al. (2012).
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol 30, 715-720.
Chan, E.Y., Longatti, A., McKnight, N.C., and Tooze, S.A. (2009a). Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism. Mol Cell Biol 29, 157-171.
Chan, E.M., Ratanasirintrawoot, S., Park, I.H., Manos, P.D., Loh, Y.H., Huo, H., Miller, J.D., Hartung, O., Rho, J., Ince, T.A., et al. (2009b). Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27, 1033-1037.
Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L.W.t., Huang, C.L., Errigo, A., Yin, Y., et al. (2014).
Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14, 796-809.
Chen, X., Tang, T.S., Tu, H., Nelson, O., Pook, M., Hammer, R., Nukina, N., and Bezprozvanny, I. (2008a). Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci 28, 12713-12724.
Chen, X., Vega, V.B., and Ng, H.H. (2008b). Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb Symp Quant Biol 73, 203-209.
Chen, X., Wu, J., Lvovskaya, S., Herndon, E., Supnet, C., and Bezprozvanny, I. (2011). Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. Mol Neurodegener 6, 81.
Cheng, L., Hansen, N.F., Zhao, L., Du, Y., Zou, C., Donovan, F.X., Chou, B.K., Zhou, G., Li, S., Dowey, S.N., et al. (2012). Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.
Cell Stem Cell 10, 337-344.
Cheong, H., Lindsten, T., Wu, J., Lu, C., and Thompson, C.B. (2011). Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A 108, 11121-11126.
Chessell, I.P., Michel, A.D., and Humphrey, P.P. (1997). Functional evidence for multiple purinoceptor subtypes in the rat medial vestibular nucleus. Neuroscience 77, 783-791.
Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123.
Chou, A.H., Yeh, T.H., Kuo, Y.L., Kao, Y.C., Jou, M.J., Hsu, C.Y., Tsai, S.R., Kakizuka, A., and Wang, H.L. (2006).
Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL.
Neurobiol Dis 21, 333-345.
Chou, A.H., Yeh, T.H., Ouyang, P., Chen, Y.L., Chen, S.Y., and Wang, H.L. (2008). Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 31, 89-101.
Chow, M.K., Mackay, J.P., Whisstock, J.C., Scanlon, M.J., and Bottomley, S.P. (2004). Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem Biophys Res Commun 322, 387-394.
Christie, A., and Butler, M. (1994). Glutamine-based dipeptides are utilized in mammalian cell culture by extracellular hydrolysis catalyzed by a specific peptidase. J Biotechnol 37, 277-290.
Chung, C.Y., Khurana, V., Auluck, P.K., Tardiff, D.F., Mazzulli, J.R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al.
(2013). Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983-987.
Ciechanover, A. (2005). Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6, 79-87.
Ciechanover, A. (2006). The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology 66, S7-19.
Clapham, D.E. (2007). Calcium signaling. Cell 131, 1047-1058.
Colomer Gould, V.F., Goti, D., Pearce, D., Gonzalez, G.A., Gao, H., Bermudez de Leon, M., Jenkins, N.A., Copeland, N.G., Ross, C.A., and Brown, D.R. (2007). A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice. Neurobiol Dis 27, 362-369.
Communi, D., Robaye, B., and Boeynaems, J.M. (1999). Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128, 1199-1206.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., et al. (2013).
Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823.
Cong, S.Y., Pepers, B.A., Evert, B.O., Rubinsztein, D.C., Roos, R.A., van Ommen, G.J., and Dorsman, J.C. (2005). Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 30, 560-571.
Conti, L., Pollard, S.M., Gorba, T., Reitano, E., Toselli, M., Biella, G., Sun, Y., Sanzone, S., Ying, Q.L., Cattaneo, E., et al.
(2005). Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3, e283.
Costa, M.C., Gomes-da-Silva, J., Miranda, C.J., Sequeiros, J., Santos, M.M., and Maciel, P. (2004). Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene.
Genomics 84, 361-373.
Cotman, C.W., Monaghan, D.T., and Ganong, A.H. (1988). Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci 11, 61-80.
Coutinho, P., and Andrade, C. (1978). Autosomal dominant system degeneration in Portuguese families of the Azores Islands.
A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 28, 703-709.
Coutinho, P., and Sequeiros, J. (1981). [Clinical, genetic and pathological aspects of Machado-Joseph disease]. J Genet Hum 29, 203-209.
Criollo, A., Vicencio, J.M., Tasdemir, E., Maiuri, M.C., Lavandero, S., and Kroemer, G. (2007). The inositol trisphosphate receptor in the control of autophagy. Autophagy 3, 350-353.
Cross, J.C., Werb, Z., and Fisher, S.J. (1994). Implantation and the placenta: key pieces of the development puzzle. Science 266, 1508-1518.
Cull-Candy, S., Brickley, S., and Farrant, M. (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11, 327-335.
Cummings, C.J., and Zoghbi, H.Y. (2000). Fourteen and counting: unraveling trinucleotide repeat diseases. Hum Mol Genet 9, 909-916.
Curtis, D.R., and Watkins, J.C. (1963). Acidic amino acids with strong excitatory actions on mammalian neurones. J Physiol 166, 1-14.
Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M.E. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
Dayan, F., Bilton, R.L., Laferriere, J., Trottier, E., Roux, D., Pouyssegur, J., and Mazure, N.M. (2009). Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. J Cell Physiol 218, 167-174.
de Chiara, C., Menon, R.P., Dal Piaz, F., Calder, L., and Pastore, A. (2005). Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. J Mol Biol 354, 883-893.
Delarasse, C., Gonnord, P., Galante, M., Auger, R., Daniel, H., Motta, I., and Kanellopoulos, J.M. (2009). Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 109, 846-857.
Demaurex, N., Lew, D.P., and Krause, K.H. (1992). Cyclopiazonic acid depletes intracellular Ca2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J Biol Chem 267, 2318-2324.
Denker, H.W. (2008). Human embryonic stem cells: the real challenge for research as well as for bioethics is still ahead of us.
Cells Tissues Organs 187, 250-256.
Dice, J.F., Terlecky, S.R., Chiang, H.L., Olson, T.S., Isenman, L.D., Short-Russell, S.R., Freundlieb, S., and Terlecky, L.J.
(1990). A selective pathway for degradation of cytosolic proteins by lysosomes. Semin Cell Biol 1, 449-455.
DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
Ding, Q., Regan, S.N., Xia, Y., Oostrom, L.A., Cowan, C.A., and Musunuru, K. (2013). Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12, 393-394.
Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. (1999). The glutamate receptor ion channels. Pharmacol Rev 51, 7-61.
Donaldson, K.M., Li, W., Ching, K.A., Batalov, S., Tsai, C.C., and Joazeiro, C.A. (2003). Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A 100, 8892-8897.
Doss-Pepe, E.W., Stenroos, E.S., Johnson, W.G., and Madura, K. (2003). Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol 23, 6469-6483.
Dubyak, G.R. (1991). Signal transduction by P2-purinergic receptors for extracellular ATP. Am J Respir Cell Mol Biol 4, 295-300.
Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R.A., Kaplan, D.R., and Greenberg, M.E.
(1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665.
Durr, A., Stevanin, G., Cancel, G., Duyckaerts, C., Abbas, N., Didierjean, O., Chneiweiss, H., Benomar, A., Lyon-Caen, O., Julien, J., et al. (1996). Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 39, 490-499.
Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68, 383-424.
Ebert, A.D., Yu, J., Rose, F.F., Jr., Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280.
Edwards, F.A., Gibb, A.J., and Colquhoun, D. (1992). ATP receptor-mediated synaptic currents in the central nervous system.
Nature 359, 144-147.
Egan, T.M., Samways, D.S., and Li, Z. (2006). Biophysics of P2X receptors. Pflugers Arch 452, 501-512.
Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., Yaron, Y., Eden, A., Yanuka, O., Benvenisty, N., et al.
(2007). Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1, 568-577.
Elkabetz, Y., Panagiotakos, G., Al Shamy, G., Socci, N.D., Tabar, V., and Studer, L. (2008). Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22, 152-165.
Ellerby, L.M., Andrusiak, R.L., Wellington, C.L., Hackam, A.S., Propp, S.S., Wood, J.D., Sharp, A.H., Margolis, R.L., Ross, C.A., Salvesen, G.S., et al. (1999a). Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J Biol Chem 274, 8730-8736.
Ellerby, L.M., Hackam, A.S., Propp, S.S., Ellerby, H.M., Rabizadeh, S., Cashman, N.R., Trifiro, M.A., Pinsky, L., Wellington, C.L., Salvesen, G.S., et al. (1999b). Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem 72, 185-195.
Ellisdon, A.M., Pearce, M.C., and Bottomley, S.P. (2007). Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J Mol Biol 368, 595-605.
Elsasser, S., Chandler-Militello, D., Muller, B., Hanna, J., and Finley, D. (2004). Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J Biol Chem 279, 26817-26822.
Eng, C.H., Yu, K., Lucas, J., White, E., and Abraham, R.T. (2011). Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal 3, ra31.
Erb, L., Liu, J., Ockerhausen, J., Kong, Q., Garrad, R.C., Griffin, K., Neal, C., Krugh, B., Santiago-Perez, L.I., Gonzalez, F.A., et al. (2001). An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol 153, 491-501.
Etchebehere, E.C., Cendes, F., Lopes-Cendes, I., Pereira, J.A., Lima, M.C., Sansana, C.R., Silva, C.A., Camargo, M.F., Santos, A.O., Ramos, C.D., et al. (2001). Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol 58, 1257-1263.